Tailoring B cell depletion therapy in MS according to memory B cell monitoring.
Giovanni NoviFrancesca BovisSabrina FabbriFrancesco TazzaPaola GazzolaIlaria MaiettaDaniela CurròNicolò BruschiLuca RoccatagliataGiacomo BoffaCaterina LapucciGiampaola PesceMaria CellerinoClaudio SolaroAlice LaroniElisabetta CapelloGianluigi MancardiMariapia SormaniMatilde IngleseAntonio UccelliPublished in: Neurology(R) neuroimmunology & neuroinflammation (2020)
This study provides Class IV evidence that for patients with MS, a memory B cell-based RTX reinfusion protocol can reduce the mean number of RTX reinfusions with persistent reduction of disease activity.